Jincheng Pharmaceuticals: Subsidiary obtains registration certificates for itraconazole enteric-coated tablets and cefoperazone sodium for injection medications.

Jin Cheng Pharmaceuticals announced that its subsidiaries Beijing Jin Cheng Tair Pharmaceuticals Co., Ltd. and controlling subsidiary Guangdong Jin Cheng Jinsu Pharmaceuticals Co., Ltd. have respectively received the "Drug Registration Certificate" issued by the National Medical Products Administration. Posaconazole enteric-coated tablets are a second-generation triazole antifungal drug used to treat invasive aspergillosis and prevent invasive aspergillus and candida infections.